Komori
No.1 (3562) · FactIncrease in interim R&D expenses

Recognition of R&D Expenses

First written in FY2022-Q3. 6 of 13 entries say "Advanced", first in FY2022. Latest entry: FY2027-H1.

13entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2023-Q2 – FY2023-Q3AdvancedFY2024-Q2 – FY2024OtherFY2025 – FY2027-H12022: 420222023: 320232024: 220242025: 220252026: 22026
Same theme, other companies
Recognition and Disclosure of R&D ExpensesA theme 73 companies write about · 0 as a headwind · 21 as a tailwind

49 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 73 companies compared. The sentences above are computed from all 73.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Increase in interim R&D expensesAnnual report

    「Total research and development expenses for the interim consolidated accounting period were ¥5.700 million.」

    Interim research and development expenses were ¥5.700 million, up from ¥454 thousand in the same period of the previous year.
  2. FY2026Decline in R&D spendingAnnual report

    「Total research and development activities for the fiscal year were ¥1.429 million.」

    Research and development expenses decreased from ¥8.139 million in the previous fiscal year to ¥1.429 million.
  3. FY2026-H1Recording of interim research and development expensesAnnual report

    「Total research and development expenses for the interim consolidated accounting period were ¥454 thousand.」

    Research and development expenses of ¥454 thousand were recorded for the interim consolidated accounting period.
  4. FY2025Decline in R&D spendingAnnual report

    「Total research and development activities for the fiscal year were ¥7.451 million.」

    Research and development expenses decreased from ¥8.139 million in the previous fiscal year to ¥7.451 million.
  5. FY2024AdvancedAnnual report

    「Total research and development activities for the fiscal year were ¥8.139 million.」

    Full-year research and development expenses were ¥8.139 million, up from ¥6.014 million in the previous fiscal year.
  6. FY2024-Q3AdvancedAnnual report

    「Total research and development expenses for the cumulative third quarter were ¥5.817 million.」

    Research and development expenses of ¥5.817 million were recorded for the cumulative third quarter, up from ¥4.480 million in the same period of the previous year.
  7. FY2024-Q2AdvancedAnnual report

    「Total R&D expenses for the 2nd quarter cumulative consolidated period were ¥4.460 million.」

    Research and development expenses of ¥4.460 million were recorded for the cumulative second quarter.
  8. FY2024-Q1RestatedAnnual report

    「Total R&D expenses for the 1st quarter cumulative consolidated period were ¥1.571 million.」

    The company states that it recorded R&D expenses of ¥1.571 million for the 1st quarter cumulative consolidated period.
  9. FY2023-Q3AdvancedAnnual report

    「Total R&D expenses for the 3rd quarter cumulative consolidated period were ¥4.955 million.」

    R&D expenses for the 3rd quarter cumulative period were ¥4.955 million, up from ¥3.559 million in the previous quarter’s cumulative period.
  10. FY2023-Q2AdvancedAnnual report

    「Total R&D expenses for the 2nd quarter cumulative consolidated period were ¥3.559 million.」

    The company recorded cumulative R&D expenses of ¥3.559 million through the 2nd quarter, up from ¥2.091 million in FY2023-Q1.
  11. FY2023-Q1RestatedAnnual report

    「Total R&D expenses for the 1st quarter cumulative consolidated period were ¥2.091 million.」

    The company states that it recorded R&D expenses of ¥2.091 million for the 1st quarter cumulative consolidated period.
  12. FY2022AdvancedAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥6.014 million.」

    The company recorded full-year R&D expenses of ¥6.014 million, up from the cumulative ¥4.480 million reported for FY2022-Q3.
  13. FY2022-Q3First statedAnnual report

    「Total R&D expenses for the 3rd quarter cumulative consolidated period were ¥4.480 million.」

    The company states that it recorded R&D expenses of ¥4.480 million for the 3rd quarter cumulative consolidated period.
Moved together

"Policy of Prioritizing Retained Earnings and Upfront Investment, with No Dividends" moved the same way as this thread, in the same document, in 6 of its 13 moves.

643333★123456
  1. ★This thread
  2. 1Policy of Prioritizing Retained Earnings and Upfront Investment, with No Dividends6×
  3. 2Expanding sales coverage and geographic reach by strengthening alliances4×
  4. 3Stabilizing the Operating Foundation and Achieving Sustained Growth3×
  5. 4Strengthening the competitiveness and expanding sales of proprietary products3×
  6. 5Strengthening Information Security Products and Solutions3×
  7. 6Sales and Profit Growth Record3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for No.1 yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Recognition of R&D Expenses | No.1 Co.,Ltd (3562) | Komori